P. Vilain

1.7k total citations
20 papers, 1.5k citations indexed

About

P. Vilain is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, P. Vilain has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 7 papers in Physiology. Recurrent topics in P. Vilain's work include Neuropeptides and Animal Physiology (15 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). P. Vilain is often cited by papers focused on Neuropeptides and Animal Physiology (15 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (6 papers). P. Vilain collaborates with scholars based in France and Italy. P. Vilain's co-authors include Xavier Emonds‐Alt, Vincenzo Proietto, Didier Van Broeck, G. Néliat, Charles Advenier, G. Le Fur, Emmanuel Naline, J. C. Brelière, Gérard Le Fur and Michel Héaulme and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Pharmacology and Experimental Therapeutics and European Respiratory Journal.

In The Last Decade

P. Vilain

19 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Vilain France 13 1.1k 953 481 264 260 20 1.5k
Vincenzo Proietto France 9 934 0.9× 731 0.8× 338 0.7× 136 0.5× 50 0.2× 9 1.1k
Didier Van Broeck France 8 917 0.8× 719 0.8× 329 0.7× 135 0.5× 48 0.2× 10 1.0k
Ayako Fukuda Japan 9 691 0.6× 783 0.8× 136 0.3× 87 0.3× 108 0.4× 13 1.4k
C. Rougeot France 16 285 0.3× 356 0.4× 177 0.4× 35 0.1× 82 0.3× 29 800
M.M.T. O’Hare Denmark 19 653 0.6× 462 0.5× 77 0.2× 92 0.3× 31 0.1× 40 1.1k
Timothy D. Westfall United Kingdom 20 155 0.1× 348 0.4× 141 0.3× 92 0.3× 55 0.2× 29 1.1k
Svend Knuhtsen Denmark 20 663 0.6× 471 0.5× 123 0.3× 42 0.2× 53 0.2× 37 1.4k
Jonathan D. Kursar United States 12 410 0.4× 439 0.5× 105 0.2× 31 0.1× 67 0.3× 13 761
S. Heisler Canada 16 222 0.2× 380 0.4× 110 0.2× 51 0.2× 67 0.3× 42 756
R.L.G. Sheldrick United Kingdom 11 231 0.2× 289 0.3× 280 0.6× 28 0.1× 63 0.2× 17 773

Countries citing papers authored by P. Vilain

Since Specialization
Citations

This map shows the geographic impact of P. Vilain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Vilain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Vilain more than expected).

Fields of papers citing papers by P. Vilain

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Vilain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Vilain. The network helps show where P. Vilain may publish in the future.

Co-authorship network of co-authors of P. Vilain

This figure shows the co-authorship network connecting the top 25 collaborators of P. Vilain. A scholar is included among the top collaborators of P. Vilain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Vilain. P. Vilain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Emonds‐Alt, Xavier, Vincenzo Proietto, R. Steinberg, et al.. (2002). Biochemical and pharmacological activities of SSR 146977, a new potent nonpeptide tachykinin NK3 receptor antagonist. Canadian Journal of Physiology and Pharmacology. 80(5). 482–488. 26 indexed citations
2.
3.
Emonds‐Alt, Xavier, Charles Advenier, Tiziano Croci, et al.. (1997). Biochemical and pharmacological activities of SR 144190, a new potent non-peptide tachykinin NK2 receptor antagonist. Neuropeptides. 31(5). 449–458. 32 indexed citations
4.
Vilain, P., Xavier Emonds‐Alt, G. Le Fur, & J. C. Brelière. (1997). Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activities. Canadian Journal of Physiology and Pharmacology. 75(6). 587–590. 5 indexed citations
5.
Gal, C. Serradeil‐Le, C Lacour, G Valette, et al.. (1996). Characterization of SR 121463A, a highly potent and selective, orally active vasopressin V2 receptor antagonist.. Journal of Clinical Investigation. 98(12). 2729–2738. 210 indexed citations
6.
Naline, Emmanuel, et al.. (1995). Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanaesthetized guinea pig. European Respiratory Journal. 8(7). 1110–1114. 66 indexed citations
7.
Emonds‐Alt, Xavier, Michel Héaulme, Brigitte Miloux, et al.. (1994). SR 142801, The first potent non-peptide antagonist of the tachykinin NK3 receptor. Life Sciences. 56(1). PL27–PL32. 201 indexed citations
8.
Naline, Emmanuel, et al.. (1994). Influence of SR48968, a neurokinin NK2-receptor antagonist, on cough induced by citric acid in conscious guinea-pig. Neuropeptides. 26. 40–40. 2 indexed citations
9.
Vilain, P., Xavier Emonds‐Alt, Charles Advenier, G. Le Fur, & J. C. Brelière. (1994). Involvement of tachykinins in the bronchospasm induced by chemicals in the guinea-pig. Inhibition by SR48968. Neuropeptides. 26. 35–35. 3 indexed citations
10.
Emonds‐Alt, Xavier, Charles Advenier, Tiziano Croci, et al.. (1993). SR 48968, a neurokinin A (NK2) receptor antagonist. Regulatory Peptides. 46(1-2). 31–36. 32 indexed citations
11.
Emonds‐Alt, Xavier, Jean-Daniel Doutremepuich, Michel Héaulme, et al.. (1993). In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. European Journal of Pharmacology. 250(3). 403–413. 337 indexed citations
12.
Vilain, P., et al.. (1993). Antitussive effect of SR 48968, a non-peptide tachykinin NK2, receptor antagonist. European Journal of Pharmacology. 250(1). 169–171. 40 indexed citations
13.
Emonds‐Alt, Xavier, Jean-Daniel Doutremepuich, M. Jung, et al.. (1993). SR 140333, a non-peptide antagonist of substance-P (NK1) receptor. Neuropeptides. 24(4). 231–231. 12 indexed citations
14.
Emonds‐Alt, Xavier, Vincenzo Proietto, Didier Van Broeck, et al.. (1993). Pharmacological profile and chemical synthesis of SR 48968, a non-peptide antagonist of the neurokinin A (NK2) receptor. Bioorganic & Medicinal Chemistry Letters. 3(5). 925–930. 22 indexed citations
15.
Emonds‐Alt, Xavier, P. Vilain, Vincenzo Proietto, et al.. (1992). A potent and selective non-peptide antagonist of the neurokinin a (NK2) receptor. Life Sciences. 50(15). PL101–PL106. 397 indexed citations
16.
Advenier, Charles, Emmanuel Naline, H Bakdach, et al.. (1992). Effects on the Isolated Human Bronchus of SR 48968, a Potent and Selective Nonpeptide Antagonist of the Neurokinin A (NK 2 ) Receptors. American Review of Respiratory Disease. 146(5_pt_1). 1177–1181. 88 indexed citations
17.
Doutremepuich, Jean-Daniel, et al.. (1992). Effect of Substance P and Sar<sup>9</sup>Met(O<sub>2</sub>)<sup>11</sup>-Substance P on Cutaneous Capillary Permeability in Guinea Pig Skin. Skin Pharmacology and Physiology. 5(3). 171–176. 2 indexed citations
18.
Emonds‐Alt, Xavier, Charles Advenier, P. Vilain, et al.. (1992). Pharmacological profile of SR 48968, a potent non-peptide antagonist of the neurokinin A (NK2) receptor. Neuropeptides. 22(1). 21–22. 9 indexed citations
19.
Tarayre, J.P., et al.. (1983). Pharmacological study of the antitussive and respiratory-analeptic properties of N-(2'-ethylpyrrolidino)diphenylacetamide hydrochloride (F 1459).. PubMed. 33(7). 931–5. 3 indexed citations
20.
Tarayre, J.P., et al.. (1979). Action of mannitol in various immunological experimental models. Inflammation Research. 9(4). 369–374.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vincenzo Proietto Breakdown of academic impact, for papers by Didier Van Broeck Breakdown of academic impact, for papers by Ayako Fukuda Breakdown of academic impact, for papers by C. Rougeot Breakdown of academic impact, for papers by M.M.T. O’Hare Breakdown of academic impact, for papers by Timothy D. Westfall Breakdown of academic impact, for papers by Svend Knuhtsen Breakdown of academic impact, for papers by Jonathan D. Kursar Breakdown of academic impact, for papers by S. Heisler Breakdown of academic impact, for papers by R.L.G. Sheldrick
Rankless by CCL
2026